DETECTION OF TP53 GENE-MUTATIONS IN HUMAN SARCOMAS

被引:31
作者
CASTRESANA, JS
RUBIO, MP
GOMEZ, L
KREICBERGS, A
ZETTERBERG, A
BARRIOS, C
机构
[1] MASSACHUSETTS GEN HOSP,MOLEC NEUROONCOL LAB,BOSTON,MA 02129
[2] MASSACHUSETTS GEN HOSP,NEUROSURG SERV,BOSTON,MA 02129
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02129
[4] KAROLINSKA HOSP,DEPT TUMOUR PATHOL,S-10401 STOCKHOLM,SWEDEN
[5] KAROLINSKA INST,DEPT TUMOUR PATHOL,S-10401 STOCKHOLM,SWEDEN
[6] KAROLINSKA INST,DEPT ORTHOPAED,S-10401 STOCKHOLM,SWEDEN
[7] KAROLINSKA HOSP,DEPT ORTHOPAED,S-10401 STOCKHOLM,SWEDEN
[8] UNIV VALENCIA,SCH MED,DEPT SURG,INST ORTHOPAED & TRAUMA,E-46010 VALENCIA,SPAIN
关键词
TUMOR SUPPRESSOR GENE; TP53; POINT MUTATION; SARCOMAS; PCR-SSCP; DIRECT SEQUENCING;
D O I
10.1016/0959-8049(95)00121-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine the frequency and type of TP53 mutations in human sarcomas, we examined exons 5-8 of the TP53 gene in 48 sarcomas using single-strand conformation polymorphism (SSCP) analysis and direct sequencing. Nine tumours had mobility-shifts on SSCP analysis, and sequencing of six of these tumours revealed 10 mutations: one insertion, two deletions and seven point mutations (four transitions and three transversions). Four of these mutations resulted in frame-shifts, one in a truncated protein, four cases in mono-allelic point mutations and one case in an altered splice site. These data show that approximately 20% of sarcomas harbour TP53 gene alterations and illustrate a variety of TP53 gene mutation types.
引用
收藏
页码:735 / 738
页数:4
相关论文
共 29 条
  • [1] ANDREASSEN A, 1993, CANCER RES, V53, P468
  • [2] SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA
    BRESSAC, B
    KEW, M
    WANDS, J
    OZTURK, M
    [J]. NATURE, 1991, 350 (6317) : 429 - 431
  • [3] LACK OF ALLELIC DELETION AND POINT MUTATION AS MECHANISMS OF P53 ACTIVATION IN HUMAN-MALIGNANT MELANOMA
    CASTRESANA, JS
    RUBIO, MP
    VAZQUEZ, JJ
    IDOATE, M
    SOBER, AJ
    SEIZINGER, BR
    BARNHILL, RL
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (04) : 562 - 565
  • [4] NO TP53 MUTATIONS IN NEUROBLASTOMAS DETECTED BY PCR-SSCP ANALYSIS
    CASTRESANA, JS
    BELLO, ML
    REY, JA
    NEBREDA, P
    QUEIZAN, A
    GARCIAMIGUEL, P
    PESTANA, A
    [J]. GENES CHROMOSOMES & CANCER, 1994, 10 (02) : 136 - 138
  • [5] GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE
    CHEN, PL
    CHEN, YM
    BOOKSTEIN, R
    LEE, WH
    [J]. SCIENCE, 1990, 250 (4987) : 1576 - 1580
  • [6] SOFT-TISSUE TUMORS - THE GENETIC-BASIS OF DEVELOPMENT
    COOPER, CS
    STRATTON, MR
    [J]. CARCINOGENESIS, 1991, 12 (02) : 155 - 165
  • [7] FRIEND SH, 1988, NEW ENGL J MED, V318, P618
  • [8] Hayashi K, 1991, PCR Methods Appl, V1, P34
  • [9] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [10] LOUIS DN, 1993, J NEUROPATHOL EXP NE, V52, P311